NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)
Last Price
0.805
Today's Change
-0.015 (1.82%)
Day's Change
0.791 - 0.85
Trading Volume
2,017,551
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Senate Panel Criticises Rising Airline Seat Fees, Will Call Execs to Testify
2
Google Arguments Draw Scepticism From Judge in Ad Tech Case
3
Tesla Excluded From EV Buyer Credits in California Proposal
4
Bitcoin Retreats From US$100,000 in Worst Spell Since Trump’s Win
5
'No One Will Win a Trade War,' China Says After Trump Tariff Threat
#
Stock
Score
AWK
American Water Works Company, Inc.
TAX
666
INSP
Inspire Medical Systems, Inc.
CPX
FBNK
6
HTGC
Hercules Capital, Inc.
7
MUR
Murphy Oil Corporation
8
ORCL
Oracle Corporation
400
9
E
Eni S.p.A.
10
FLOW
Global X U.S. Cash Flow Kings 100 ETF
333
Last
Change
Volume
MSTZ
1.02
-0.26
438,564,456
SLNA
0.03
-0.008
379,091,456
CYXT
0.065
0.00
369,807,727
IDAI
0.84
+0.475
363,250,695
VCIG
4.10
+2.28
255,037,719
UWT
0.164
-0.002
244,137,454
NVDA
135.34
-1.58
218,142,891
OPTT
0.369
+0.077
209,493,082
AGIL
0.197
+0.114
206,404,986
LYLT
0.218
204,480,452
BRK-A
723,548.96
+5,029.00
1,624
RTLA
209.90
+74.87
0
TPL
1,636.69
+64.92
416,552
AZO
3,190.10
+45.89
133,819
MSTR
388.84
+35.15
34,352,766
ACSG
33.28
+33.28
99,050
EMSA
140.77
+30.77
EMLB
80.80
+30.30
NOVVU
41.00
+28.85
17,976
NOVV
37.00
+23.46
205,220
MELI
1,774.05
-343.25
2,940,447
MPWR
592.31
-168.99
175,940
1,309.00
-138.99
2,237,917
PGHL
2.14
-105.22
17,601,024
MKL
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....